Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 144 Insider Sale of Securities
  2. EFFECT Other Notice of Effectiveness
  3. DEL AM Other DEL AM
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. ARS Other Annual Report to Security Holders
  10. DEFA14A Proxy Proxy Materials
  11. 144 Insider Sale of Securities
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. SC TO-C Deal Written Communication Relating to an Issuer
  14. 144 Insider Sale of Securities
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. DEFA14A Proxy Proxy Materials
  18. DEFA14A Proxy Proxy Materials
  19. DEFA14A Proxy Proxy Materials
  20. ARS Other Annual Report to Security Holders

Page 1 of 3 · 59 filings